| Toggle Summary
|
MediWound Expands Distribution of NexoBrid to Mexico through Agreement with COVALEO SA
|
View HTML
|
| Toggle Summary
|
MediWound to Present at Oppenheimer 25th Annual Healthcare Conference
|
View HTML
|
| Toggle Summary
|
MediWound to Present at Two Upcoming Investor Conferences
|
View HTML
|
| Toggle Summary
|
MediWound Reports Third Quarter 2014 Financial Results
|
View HTML
|
| Toggle Summary
|
MediWound Initiates Post-Marketing Study with NexoBrid® to Treat Severe Burns in Pediatric Patients
|
View HTML
|
| Toggle Summary
|
MediWound to Host Third Quarter 2014 Financial Results Conference Call on November 5, 2014 at 4:30 p.m. Eastern Time
|
View HTML
|
| Toggle Summary
|
MediWound's NexoBrid to be Featured at International Society for Burn Injuries 2014
Multiple Oral and Poster Presentations Highlight NexoBrid's Innovative, Effective and Fast Enzymatic Debriding of Severe Burns
|
View HTML
|
| Toggle Summary
|
MediWound Reports Second Quarter 2014 Financial Results
Conference Call Begins Today at 8:30 a.m. Eastern Time
|
View HTML
|
| Toggle Summary
|
MediWound to Host Second Quarter 2014 Financial Results Conference Call on July 31, 2014 at 8:30 a.m.
|
View HTML
|
| Toggle Summary
|
MediWound Announces NexoBrid Marketing Approval From Israeli Ministry of Health
Market Launch Planned for This Quarter
|
View HTML
|
